A Phase 2 Study Evaluating the Safety and Efficacy of Netarsudil Ophthalmic Solution in Patients With Corneal Edema Due to Fuchs Corneal Dystrophy

NCT04498169 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Corneal Edema

Interventions

DRUG: Netarsudil Ophthalmic
DRUG: Netarsudil Ophthalmic

Sponsor

Aerie Pharmaceuticals